<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35223894</PMID><DateRevised><Year>2022</Year><Month>05</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Long-Term Persisting SARS-CoV-2 RNA and Pathological Findings: Lessons Learnt From a Series of 35 COVID-19 Autopsies.</ArticleTitle><Pagination><StartPage>778489</StartPage><MedlinePgn>778489</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">778489</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2022.778489</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Long-term sequelae of coronavirus disease 2019 (COVID-19), including the interaction between persisting viral-RNA and specific tissue involvement, pose a challenging issue. In this study, we addressed the chronological correlation (after first clinical diagnosis and postmortem) between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA and organ involvement.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The presence of postmortem SARS-CoV-2 RNA from 35 complete COVID-19 autopsies was correlated with the time interval between the first diagnosis of COVID-19 and death and with its relationship to morphologic findings.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA can be evident up to 40 days after the first diagnosis and can persist to 94 hours after death. Postmortem SARS-CoV-2 RNA was mostly positive in lungs (70%) and trachea (69%), but all investigated organs were positive with variable frequency. Late-stage tissue damage was evident up to 65 days after initial diagnosis in several organs. Positivity for SARS-CoV-2 RNA in pulmonary swabs correlated with diffuse alveolar damage (<i>p</i> = 0.0009). No correlation between positive swabs and other morphologic findings was present. Cerebral (<i>p</i> = 0.0003) and systemic hemorrhages (<i>p</i> = 0.009), cardiac thrombi (<i>p</i> = 0.04), and ischemic events (<i>p</i> = 0.03) were more frequent in the first wave, whereas bacterial pneumonia (<i>p</i> = 0.03) was more prevalent in the second wave. No differences in biometric data, clinical comorbidities, and other autopsy findings were found.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our data provide evidence not only of long-term postmortem persisting SARS-CoV-2 RNA but also of tissue damage several weeks after the first diagnosis of SARS-CoV-2 infection. Additional conditions, such as concomitant bacterial pulmonary superinfection, lung aspergillosis, thromboembolic phenomena, and hemorrhages can further worsen tissue damage.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Maccio, Zinkernagel, Schuepbach, Probst-Mueller, Frontzek, Brugger, Hofmaenner, Moch and Varga.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maccio</LastName><ForeName>Umberto</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Pathology and Molecular Pathology, University Hospital of Z&#xfc;rich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zinkernagel</LastName><ForeName>Annelies S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Hospital Epidemiology, University Hospital of Z&#xfc;rich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuepbach</LastName><ForeName>Reto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Intensive Care, University Hospital Zurich, University Hospital of Z&#xfc;rich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Probst-Mueller</LastName><ForeName>Elsbeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Immunology, University Hospital of Z&#xfc;rich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frontzek</LastName><ForeName>Karl</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute of Neuropathology, University Hospital Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brugger</LastName><ForeName>Silvio D</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Hospital Epidemiology, University Hospital of Z&#xfc;rich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hofmaenner</LastName><ForeName>Daniel Andrea</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Institute of Intensive Care, University Hospital Zurich, University Hospital of Z&#xfc;rich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moch</LastName><ForeName>Holger</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pathology and Molecular Pathology, University Hospital of Z&#xfc;rich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varga</LastName><ForeName>Zsuzsanna</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Pathology and Molecular Pathology, University Hospital of Z&#xfc;rich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 RNA PCR</Keyword><Keyword MajorTopicYN="N">autopsy</Keyword><Keyword MajorTopicYN="N">histopathology</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">postmortal swabs</Keyword><Keyword MajorTopicYN="N">pulmonary superinfections</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>28</Day><Hour>5</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35223894</ArticleId><ArticleId IdType="pmc">PMC8865372</ArticleId><ArticleId IdType="doi">10.3389/fmed.2022.778489</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. . A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. (2020) 382:727&#x2013;33. 10.1056/NEJMoa2001017</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. . 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. (2021) 397:220&#x2013;32. 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. . Post-acute COVID-19 syndrome. Nat Med. (2021) 27:601&#x2013;15. 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Oran DP, Topol EJ. The proportion of SARS-CoV-2 infections that are asymptomatic: a systematic review. Ann Intern Med. (2021) 174:655&#x2013;62. 10.7326/M20-6976</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-6976</ArticleId><ArticleId IdType="pmc">PMC7839426</ArticleId><ArticleId IdType="pubmed">33481642</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019. (COVID-19) outbreak in china: summary of a report of 72314 cases from the chinese center for disease control and prevention. JAMA. (2020) 323:1239&#x2013;42. 10.1001/jama.2020.2648</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant MC, Geoghegan L, Arbyn M, Mohammed Z, McGuinness L, Clarke EL, et al. . The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries. PLoS ONE. (2020) 15:e0234765. 10.1371/journal.pone.0234765</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0234765</ArticleId><ArticleId IdType="pmc">PMC7310678</ArticleId><ArticleId IdType="pubmed">32574165</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. . Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. (2020) 323:1061&#x2013;9. 10.1001/jama.2020.1585</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, et al. . High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. (2020) 46:1089&#x2013;98. 10.1007/s00134-020-06062-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06062-x</ArticleId><ArticleId IdType="pmc">PMC7197634</ArticleId><ArticleId IdType="pubmed">32367170</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo W YH, Gou J, Li X, Sun Y, Li J, Liu L. Clinical pathology of critical patient with novel coronavirus pneumonia (COVID-19). Preprints. (2020).</Citation></Reference><Reference><Citation>Liotta EM, Batra A, Clark JR, Shlobin NA, Hoffman SC, Orban ZS, et al. . Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients. Ann Clin Transl Neurol. (2020) 7:2221&#x2013;30. 10.1002/acn3.51210</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51210</ArticleId><ArticleId IdType="pmc">PMC7664279</ArticleId><ArticleId IdType="pubmed">33016619</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019. (COVID-19): A Review. JAMA. (2020) 324:782&#x2013;93. 10.1001/jama.2020.12839</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12839</ArticleId><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. (2020) 395:497&#x2013;506. 10.1016/S0140-6736(20)30183-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, et al. . COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. (2020) 395:1033&#x2013;4. 10.1016/S0140-6736(20)30628-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30628-0</ArticleId><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartoletti M, Pascale R, Cricca M, Rinaldi M, Maccaro A, Bussini L, et al. . Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study. Clin Infect Dis. (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454393</ArticleId><ArticleId IdType="pubmed">32719848</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, et al. . Bacterial and fungal coinfection in individuals with coronavirus: a rapid review To support COVID-19 antimicrobial prescribing. Clin Infect Dis. (2020) 71:2459&#x2013;68. 10.1093/cid/ciaa530</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa530</ArticleId><ArticleId IdType="pmc">PMC7197596</ArticleId><ArticleId IdType="pubmed">32358954</ArticleId></ArticleIdList></Reference><Reference><Citation>Sepulveda J, Westblade LF, Whittier S, Satlin MJ, Greendyke WG, Aaron JG, et al. . Bacteremia and blood culture utilization during COVID-19 surge in New York City. J Clin Microbiol. (2020) 58. 10.1128/JCM.00875-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00875-20</ArticleId><ArticleId IdType="pmc">PMC7383550</ArticleId><ArticleId IdType="pubmed">32404482</ArticleId></ArticleIdList></Reference><Reference><Citation>Buehler PK, Zinkernagel AS, Hofmaenner DA, Wendel Garcia PD, Acevedo CT, Gomez-Mejia A, et al. . Bacterial pulmonary superinfections are associated with longer duration of ventilation in critically ill COVID-19 patients. Cell Rep Med. (2021) 2:100229. 10.1016/j.xcrm.2021.100229</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2021.100229</ArticleId><ArticleId IdType="pmc">PMC7955928</ArticleId><ArticleId IdType="pubmed">33748789</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyerowitz-Katz G, Merone L. A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates. Int J Infect Dis. (2020) 101:138&#x2013;48. 10.1016/j.ijid.2020.09.1464</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.09.1464</ArticleId><ArticleId IdType="pmc">PMC7524446</ArticleId><ArticleId IdType="pubmed">33007452</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. (2020) 395:1054&#x2013;62. 10.1016/S0140-6736(20)30566-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA. (2020) 323:1775&#x2013;6. 10.1001/jama.2020.4683</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.4683</ArticleId><ArticleId IdType="pubmed">32203977</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M. A'Court C, Buxton M, Husain L. Management of post-acute Covid-19 in primary care. BMJ. (2020) 370:m3026. 10.1136/bmj.m3026</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Penas C, Palacios-Cena D, Gomez-Mayordomo V, Cuadrado ML, Florencio LL. Defining post-COVID symptoms (Post-Acute COVID, long COVID, persistent post-COVID): an integrative classification. Int J Environ Res Public Health. (2021) 18. 10.3390/ijerph18052621</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18052621</ArticleId><ArticleId IdType="pmc">PMC7967389</ArticleId><ArticleId IdType="pubmed">33807869</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, et al. . SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and Is blocked by a clinically proven protease inhibitor. Cell. (2020) 181:271&#x2013;80 e8. 10.1016/j.cell.2020.02.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K, Chen W, Zhang Z, Deng Y, Lian JQ, Du P, et al. . CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct Target Ther. (2020) 5:283. 10.1038/s41392-020-00426-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00426-x</ArticleId><ArticleId IdType="pmc">PMC7714896</ArticleId><ArticleId IdType="pubmed">33277466</ArticleId></ArticleIdList></Reference><Reference><Citation>Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. (2020) 183:1735. 10.1016/j.cell.2020.11.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.11.032</ArticleId><ArticleId IdType="pmc">PMC7833104</ArticleId><ArticleId IdType="pubmed">33306958</ArticleId></ArticleIdList></Reference><Reference><Citation>Chauhan AJ, Wiffen LJ, Brown TP. COVID-19: A collision of complement, coagulation and inflammatory pathways. J Thromb Haemost. (2020) 18:2110&#x2013;7. 10.1111/jth.14981</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14981</ArticleId><ArticleId IdType="pmc">PMC7361520</ArticleId><ArticleId IdType="pubmed">32608159</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol. (2021) 93:250&#x2013;6. 10.1002/jmv.26232</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26232</ArticleId><ArticleId IdType="pmc">PMC7361342</ArticleId><ArticleId IdType="pubmed">32592501</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Channappanavar R, Kanneganti TD. Coronaviruses: innate immunity, inflammasome activation, inflammatory cell death, and cytokines. Trends Immunol. (2020) 41:1083&#x2013;99. 10.1016/j.it.2020.10.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2020.10.005</ArticleId><ArticleId IdType="pmc">PMC7561287</ArticleId><ArticleId IdType="pubmed">33153908</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo MW, Kemper C, Woodruff TM. COVID-19: Complement, coagulation, and collateral damage. J Immunol. (2020) 205:1488&#x2013;95. 10.4049/jimmunol.2000644</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2000644</ArticleId><ArticleId IdType="pmc">PMC7484432</ArticleId><ArticleId IdType="pubmed">32699160</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekhawat V, Green A, Mahadeva U. COVID-19 autopsies: conclusions from international studies. Diagn Histopathol (Oxf). (2021) 27:103&#x2013;7. 10.1016/j.mpdhp.2020.11.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mpdhp.2020.11.008</ArticleId><ArticleId IdType="pmc">PMC7719010</ArticleId><ArticleId IdType="pubmed">33312230</ArticleId></ArticleIdList></Reference><Reference><Citation>Salerno M, Sessa F, Piscopo A, Montana A, Torrisi M, Patane F, et al. . No Autopsies on COVID-19 Deaths: A Missed Opportunity and the Lockdown of Science. J Clin Med. (2020) 9. 10.3390/jcm9051472</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9051472</ArticleId><ArticleId IdType="pmc">PMC7291342</ArticleId><ArticleId IdType="pubmed">32422983</ArticleId></ArticleIdList></Reference><Reference><Citation>Organisation WH . Infection prevention and control for the safe management of a dead body in the context of COVID-19: interim guidance, 24 March 2020. Available online at: https://appswhoint/iris/handle/10665/331538. (2020).</Citation></Reference><Reference><Citation>(CDC) . CfDCaP. Collection and submission of postmortem specimens from deceased persons with known or suspected COVID-19, March 2020. (Interim guidance) (2020). Available online at: https://wwwcdcgov/coronavirus/2019-ncov/hcp/guidance-postmortem-specimenshtml (2020).</Citation></Reference><Reference><Citation>Control ECfDPa. Considerations related to the safe handling of bodies of deceased persons with suspected or confirmed COVID-19. Available online at: https://wwwecdceuropaeu/en/publications-data/considerations-related-safe-handling-bodies-deceased-persons-suspected-or (2020).</Citation></Reference><Reference><Citation>Satturwar S, Fowkes M, Farver C, Wilson AM, Eccher A, Girolami I, et al. . Postmortem findings associated with SARS-CoV-2: systematic review and meta-analysis. Am J Surg Pathol. (2021) 45:587&#x2013;603. 10.1097/PAS.0000000000001650</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PAS.0000000000001650</ArticleId><ArticleId IdType="pmc">PMC8132567</ArticleId><ArticleId IdType="pubmed">33481385</ArticleId></ArticleIdList></Reference><Reference><Citation>Croci GA, Vaira V, Trabattoni D, Biasin M, Valenti L, Baselli G, et al. . Emergency lung transplantation after COVID-19: immunopathological insights on two affected patients. Cells. (2021) 10. 10.3390/cells10030611</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10030611</ArticleId><ArticleId IdType="pmc">PMC7999589</ArticleId><ArticleId IdType="pubmed">33801959</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmieri L, Palmer K, Lo Noce C, Meli P, Giuliano M, Floridia M, et al. . Differences in the clinical characteristics of COVID-19 patients who died in hospital during different phases of the pandemic: national data from Italy. Aging Clin Exp Res. (2021) 33:193&#x2013;9. 10.1007/s40520-020-01764-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-020-01764-0</ArticleId><ArticleId IdType="pmc">PMC7750107</ArticleId><ArticleId IdType="pubmed">33345291</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano V, Ganado-Pinilla P, Sanchez-Santos M, Gomez-Gallego F, Barreiro P, de Mendoza C, et al. . Main differences between the first and second waves of COVID-19 in Madrid, Spain. Int J Infect Dis. (2021) 105:374&#x2013;6. 10.1016/j.ijid.2021.02.115</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.02.115</ArticleId><ArticleId IdType="pmc">PMC7934652</ArticleId><ArticleId IdType="pubmed">33684560</ArticleId></ArticleIdList></Reference><Reference><Citation>Deinhardt-Emmer S, Wittschieber D, Sanft J, Kleemann S, Elschner S, Haupt KF, et al. . Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage. Elife. (2021) 10. 10.7554/eLife.60361</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.60361</ArticleId><ArticleId IdType="pmc">PMC8009677</ArticleId><ArticleId IdType="pubmed">33781385</ArticleId></ArticleIdList></Reference><Reference><Citation>Dell'Aquila M, Cattani P, Fantoni M, Marchetti S, Aquila I, Stigliano E, et al. . Postmortem swabs in the severe acute respiratory syndrome coronavirus 2 pandemic: report on 12 complete clinical autopsy cases. Arch Pathol Lab Med. (2020). 144(11):1298&#x2013;302. 10.5858/arpa.2020-0362-SA</Citation><ArticleIdList><ArticleId IdType="doi">10.5858/arpa.2020-0362-SA</ArticleId><ArticleId IdType="pubmed">32589448</ArticleId></ArticleIdList></Reference><Reference><Citation>Skok K, Stelzl E, Trauner M, Kessler HH, Lax SF. Post-mortem viral dynamics and tropism in COVID-19 patients in correlation with organ damage. Virchows Arch. (2021) 478:343&#x2013;53. 10.1007/s00428-020-02903-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00428-020-02903-8</ArticleId><ArticleId IdType="pmc">PMC7438212</ArticleId><ArticleId IdType="pubmed">32815036</ArticleId></ArticleIdList></Reference><Reference><Citation>Skok K, Vander K, Setaffy L, Kessler HH, Aberle S, Bargfrieder U, et al. . COVID-19 autopsies: Procedure, technical aspects and cause of fatal course. Experiences from a single-center Pathol Res Pract. (2021) 217:153305. 10.1016/j.prp.2020.153305</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prp.2020.153305</ArticleId><ArticleId IdType="pmc">PMC7699304</ArticleId><ArticleId IdType="pubmed">33285423</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronavirus ac. Available online at: https://www.bag.admin.ch/bag/en/home/krankheiten/ausbrueche-epidemien-pandemien/aktuelle-ausbrueche-epidemien/novel-cov.html</Citation></Reference><Reference><Citation>Wolfisberg S, Gregoriano C, Struja T, Kutz A, Koch D, Bernasconi L, et al. . Comparison of characteristics, predictors and outcomes between the first and second COVID-19 waves in a tertiary care centre in Switzerland: an observational analysis. Swiss Med Wkly. (2021) 151:w20569. 10.4414/smw.2021.20569</Citation><ArticleIdList><ArticleId IdType="doi">10.4414/smw.2021.20569</ArticleId><ArticleId IdType="pubmed">34375985</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . WHO. SARS-CoV-2 variants. (2021). Available online at: https://wwwwhoint/en/activities/tracking-SARS-CoV-2-variants/</Citation></Reference><Reference><Citation>Caramaschi S, Kapp ME, Miller SE, Eisenberg R, Johnson J, Epperly G, et al. . Histopathological findings and clinicopathologic correlation in COVID-19: a systematic review. Mod Pathol. (2021). 10.1038/s41379-021-00814-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41379-021-00814-w</ArticleId><ArticleId IdType="pmc">PMC8141548</ArticleId><ArticleId IdType="pubmed">34031537</ArticleId></ArticleIdList></Reference><Reference><Citation>Chougar L, Shor N, Weiss N, Galanaud D, Leclercq D, Mathon B, et al. . Retrospective observational study of brain MRI findings in patients with acute SARS-CoV-2 infection and neurologic manifestations. Radiology. (2020) 297:E313&#x2013;E23. 10.1148/radiol.2020202422</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020202422</ArticleId><ArticleId IdType="pmc">PMC7370354</ArticleId><ArticleId IdType="pubmed">32677875</ArticleId></ArticleIdList></Reference><Reference><Citation>Egbert AR, Cankurtaran S, Karpiak S. Brain abnormalities in COVID-19 acute/subacute phase: A rapid systematic review. Brain Behav Immun. (2020) 89:543&#x2013;54. 10.1016/j.bbi.2020.07.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.07.014</ArticleId><ArticleId IdType="pmc">PMC7366124</ArticleId><ArticleId IdType="pubmed">32682993</ArticleId></ArticleIdList></Reference><Reference><Citation>Kantonen J, Mahzabin S, Mayranpaa MI, Tynninen O, Paetau A, Andersson N, et al. . Neuropathologic features of four autopsied COVID-19 patients. Brain Pathol. (2020) 30:1012&#x2013;6. 10.1111/bpa.12889</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12889</ArticleId><ArticleId IdType="pmc">PMC7436498</ArticleId><ArticleId IdType="pubmed">32762083</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremer S, Lersy F, de Seze J, Ferre JC, Maamar A, Carsin-Nicol B, et al. . Brain MRI findings in severe COVID-19: A retrospective observational study. Radiology. (2020) 297:E242&#x2013;E51. 10.1148/radiol.2020202222</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020202222</ArticleId><ArticleId IdType="pmc">PMC7301613</ArticleId><ArticleId IdType="pubmed">32544034</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin E, Lantos JE, Strauss SB, Phillips CD, Campion TR, Jr., Navi BB, et al. . Brain imaging of patients with COVID-19: findings at an academic institution during the height of the outbreak in New York City. AJNR Am J Neuroradiol. (2020) 41:2001&#x2013;8. 10.3174/ajnr.A6793</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A6793</ArticleId><ArticleId IdType="pmc">PMC7658823</ArticleId><ArticleId IdType="pubmed">32819899</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi Y, Lee MK. Neuroimaging findings of brain MRI and CT in patients with COVID-19: A systematic review and meta-analysis. Eur J Radiol. (2020) 133:109393. 10.1016/j.ejrad.2020.109393</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejrad.2020.109393</ArticleId><ArticleId IdType="pmc">PMC7606068</ArticleId><ArticleId IdType="pubmed">33161199</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirschenbaum D, Imbach LL, Rushing EJ, Frauenknecht KBM, Gascho D, Ineichen BV, et al. . Intracerebral endotheliitis and microbleeds are neuropathological features of COVID-19. Neuropathol Appl Neurobiol. (2021) 47:454&#x2013;9. 10.1111/nan.12677</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12677</ArticleId><ArticleId IdType="pmc">PMC7753688</ArticleId><ArticleId IdType="pubmed">33249605</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanou EM, Coutinho JM, Shannon P, Kiehl TR, Levi MM, Wilcox ME, et al. . Critical Illness-Associated Cerebral Microbleeds. Stroke. (2017) 48:1085&#x2013;7. 10.1161/STROKEAHA.116.016289</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.116.016289</ArticleId><ArticleId IdType="pubmed">28235962</ArticleId></ArticleIdList></Reference><Reference><Citation>Nori P, Cowman K, Chen V, Bartash R, Szymczak W, Madaline T, et al. . Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York City pandemic surge. Infect Control Hosp Epidemiol. (2021) 42:84&#x2013;8. 10.1017/ice.2020.368</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ice.2020.368</ArticleId><ArticleId IdType="pmc">PMC7417979</ArticleId><ArticleId IdType="pubmed">32703320</ArticleId></ArticleIdList></Reference><Reference><Citation>Dudoignon E, Camelena F, Deniau B, Habay A, Coutrot M, Ressaire Q, et al. . Bacterial pneumonia in COVID-19 critically ill patients: a case series. Clin Infect Dis. (2021) 72:905&#x2013;6. 10.1093/cid/ciaa762</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa762</ArticleId><ArticleId IdType="pmc">PMC7337703</ArticleId><ArticleId IdType="pubmed">32544219</ArticleId></ArticleIdList></Reference><Reference><Citation>Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. (2020) 81:266&#x2013;75. 10.1016/j.jinf.2020.05.046</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.05.046</ArticleId><ArticleId IdType="pmc">PMC7255350</ArticleId><ArticleId IdType="pubmed">32473235</ArticleId></ArticleIdList></Reference><Reference><Citation>El Bouzidi K, Howard M, Ali H, Khan M, Harris A, Zuckerman M. 'Test, test, test' even after death: persistence of SARS-CoV-2 RNA in postmortem nasopharyngeal swabs. J Clin Pathol. (2020). 10.1136/jclinpath-2020-207091</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jclinpath-2020-207091</ArticleId><ArticleId IdType="pubmed">33184063</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawant OB, Singh S, Wright RE, 3rd, Jones KM, Titus MS, Dennis E, et al. . Prevalence of SARS-CoV-2 in human post-mortem ocular tissues. Ocul Surf. (2021) 19:322&#x2013;9. 10.1016/j.jtos.2020.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtos.2020.11.002</ArticleId><ArticleId IdType="pmc">PMC7649030</ArticleId><ArticleId IdType="pubmed">33176215</ArticleId></ArticleIdList></Reference><Reference><Citation>Servadei F, Mauriello S, Scimeca M, Caggiano B, Ciotti M, Anemona L, et al. . Persistence of SARS-CoV-2 Viral RNA in nasopharyngeal swabs after death: an observational study. Microorganisms. (2021). 9. 10.3390/microorganisms9040800</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9040800</ArticleId><ArticleId IdType="pmc">PMC8103507</ArticleId><ArticleId IdType="pubmed">33920259</ArticleId></ArticleIdList></Reference><Reference><Citation>Beltempo P, Curti SM, Maserati R, Gherardi M, Castelli M. Persistence of SARS-CoV-2 RNA in post-mortem swab 35 days after death: A case report. Forensic Sci Int. (2021) 319:110653. 10.1016/j.forsciint.2020.110653</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.forsciint.2020.110653</ArticleId><ArticleId IdType="pmc">PMC7725267</ArticleId><ArticleId IdType="pubmed">33360242</ArticleId></ArticleIdList></Reference><Reference><Citation>Braunstein GD, Schwartz L, Hymel P, Fielding J. False positive results with SARS-CoV-2 RT-PCR tests and how to evaluate a RT-PCR-positive test for the possibility of a false positive result. J Occup Environ Med. (2021) 63:e159&#x2013;e62. 10.1097/JOM.0000000000002138</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JOM.0000000000002138</ArticleId><ArticleId IdType="pmc">PMC7934325</ArticleId><ArticleId IdType="pubmed">33405498</ArticleId></ArticleIdList></Reference><Reference><Citation>Skittrall JP, Wilson M, Smielewska AA, Parmar S, Fortune MD, Sparkes D, et al. . Specificity and positive predictive value of SARS-CoV-2 nucleic acid amplification testing in a low-prevalence setting. Clin Microbiol Infect. (2021). 27:469 e9&#x2013;e15. 10.1016/j.cmi.2020.10.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.10.003</ArticleId><ArticleId IdType="pmc">PMC7554481</ArticleId><ArticleId IdType="pubmed">33068757</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall JA, Harris RJ, Emmett HE, Lowe B, Singanayagam A, Twohig KA, et al. . On the sensitivity and specificity of postmortem upper respiratory tract testing for SARS-CoV-2. J Infect Dis. (2021) 224:389&#x2013;94. 10.1093/infdis/jiab270</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab270</ArticleId><ArticleId IdType="pmc">PMC8194530</ArticleId><ArticleId IdType="pubmed">33999152</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaafar R, Aherfi S, Wurtz N, Grimaldier C, Van Hoang T, Colson P, et al. . Correlation between 3790 quantitative polymerase chain reaction-positives samples and positive cell cultures, including 1941. Severe acute respiratory syndrome coronavirus 2 isolates. Clin Infect Dis. (2021) 72:e921. 10.1093/cid/ciab531</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab531</ArticleId><ArticleId IdType="pmc">PMC7543373</ArticleId><ArticleId IdType="pubmed">32986798</ArticleId></ArticleIdList></Reference><Reference><Citation>England JT, Abdulla A, Biggs CM, Lee AYY, Hay KA, Hoiland RL, et al. . Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes. Blood Rev. (2021) 45:100707. 10.1016/j.blre.2020.100707</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.blre.2020.100707</ArticleId><ArticleId IdType="pmc">PMC7227559</ArticleId><ArticleId IdType="pubmed">32425294</ArticleId></ArticleIdList></Reference><Reference><Citation>Karki R, Sharma BR, Tuladhar S, Williams EP, Zalduondo L, Samir P, et al. . Synergism of TNF-alpha and IFN-gamma triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell. (2021). 184:149&#x2013;68 e17. 10.1016/j.cell.2020.11.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.11.025</ArticleId><ArticleId IdType="pmc">PMC7674074</ArticleId><ArticleId IdType="pubmed">33278357</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicosia RF, Ligresti G, Caporarello N, Akilesh S, Ribatti D. COVID-19 Vasculopathy: mounting evidence for an indirect mechanism of endothelial injury. Am J Pathol. (2021). 10.1016/j.ajpath.2021.05.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2021.05.007</ArticleId><ArticleId IdType="pmc">PMC8141344</ArticleId><ArticleId IdType="pubmed">34033751</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragab D, Salah Eldin H, Taeimah M, Khattab R, Salem R. The COVID-19 cytokine storm; what we know so far. Front Immunol. (2020) 11:1446. 10.3389/fimmu.2020.01446</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01446</ArticleId><ArticleId IdType="pmc">PMC7308649</ArticleId><ArticleId IdType="pubmed">32612617</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Wu H, Yao X, Zhang D, Zhou Y, Fu B, et al. . Pyroptotic macrophages stimulate the SARS-CoV-2-associated cytokine storm. Cell Mol Immunol. (2021) 18:1305&#x2013;7. 10.1038/s41423-021-00665-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-021-00665-0</ArticleId><ArticleId IdType="pmc">PMC7976727</ArticleId><ArticleId IdType="pubmed">33742186</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>